Ovid Therapeutics, Inc. (OVID)
2.375
-0.10
(-3.85%)
USD |
NASDAQ |
Oct 22, 16:00
2.375
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Price to Book Value : 2.091 for Oct. 22, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 21, 2026 | 2.174 |
| October 20, 2026 | 2.077 |
| October 19, 2026 | 1.910 |
| October 16, 2026 | 1.892 |
| October 15, 2026 | 1.989 |
| October 14, 2026 | 1.928 |
| October 13, 2026 | 1.928 |
| October 12, 2026 | 2.121 |
| October 09, 2026 | 2.165 |
| October 08, 2026 | 2.060 |
| October 07, 2026 | 2.077 |
| October 06, 2026 | 2.086 |
| October 05, 2026 | 2.060 |
| October 02, 2026 | 2.095 |
| October 01, 2026 | 2.139 |
| September 30, 2026 | 2.192 |
| September 29, 2026 | 2.236 |
| September 28, 2026 | 2.165 |
| September 25, 2026 | 2.113 |
| September 24, 2026 | 2.196 |
| September 23, 2026 | 2.262 |
| September 22, 2026 | 2.430 |
| September 21, 2026 | 2.386 |
| September 18, 2026 | 2.368 |
| September 17, 2026 | 2.377 |
| Date | Value |
|---|---|
| September 16, 2026 | 2.359 |
| September 15, 2026 | 2.386 |
| September 14, 2026 | 2.412 |
| September 11, 2026 | 2.368 |
| September 10, 2026 | 2.315 |
| September 09, 2026 | 2.377 |
| September 08, 2026 | 2.421 |
| September 04, 2026 | 2.465 |
| September 03, 2026 | 2.447 |
| September 02, 2026 | 2.386 |
| September 01, 2026 | 2.430 |
| August 31, 2026 | 2.350 |
| August 28, 2026 | 2.465 |
| August 27, 2026 | 2.579 |
| August 26, 2026 | 2.535 |
| August 25, 2026 | 2.562 |
| August 24, 2026 | 2.482 |
| August 21, 2026 | 2.465 |
| August 20, 2026 | 2.412 |
| August 19, 2026 | 2.579 |
| August 18, 2026 | 2.500 |
| August 17, 2026 | 2.544 |
| August 14, 2026 | 2.491 |
| August 13, 2026 | 2.465 |
| August 12, 2026 | 2.306 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.675 |
| Alnylam Pharmaceuticals, Inc. | 22.45 |
| Anika Therapeutics, Inc. | 2.049 |
| Savara, Inc. | 6.491 |
| Vericel Corp. | 5.944 |
Price to Book Value Related Metrics
| PS Ratio | 182.44 |
| Price | 2.375 |
| Earnings Yield | -10.67% |
| Market Cap | 438.79M |